A detailed history of Colonial Trust CO / Sc transactions in United Therapeutics Corp stock. As of the latest transaction made, Colonial Trust CO / Sc holds 8 shares of UTHR stock, worth $2,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Holding current value
$2,886
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $2,488 - $2,908
8 New
8 $2,000
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $5,507 - $6,454
26 New
26 $5,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.